Melanie M.

Melanie M. is a Senior Biologist specializing in RNA Therapeutics at Eli Lilly and Company, where they have advanced from a Medicines Innovation Hub Intern to a Principal Biologist in the Lilly Genetic Medicine department. They previously conducted research as an Undergraduate Researcher in the Paschou Lab at Purdue University, where they calculated polygenic risk scores and implemented quality control procedures in genetic studies. Melanie holds a Master's of Science in Pharmaceutical Sciences with a focus on Pharmacogenomics and Personalized Healthcare from the University of Cincinnati, as well as dual bachelor's degrees in Genetics and Global Studies from Purdue University. With a strong academic record, they have also contributed to research at institutions such as the National Human Genome Research Institute and the Indiana University School of Medicine.